Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives

por Barroso-Sousa, Romualdo, Silva, Danilo DA Fonseca Reis, Alessi, Joao Victor Machado, Mano, Max Senna
Publicado 2016

Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient

por Ribeiro, Maurício Fernando Silva Almeida, Knebel, Franciele Hinterholz, Bettoni, Fabiana, Saddi, Rodrigo, Sacardo, Karina Perez, Canedo, Felipe Sales Nogueira Amorim, Alessi, João Victor Machado, Shimada, Andrea Kazumi, Marin, José Flávio Gomes, Camargo, Anamaria Aranha, Katz, Artur
Publicado 2021

Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma

por Ribeiro, Maurício Fernando Silva Almeida, Gadotti, Luiza Lara, Sacardo, Karina Perez, Lopes, Carlos Diego Holanda, Saddi, Rodrigo, Alessi, João Victor Machado, de Macedo, Mariana Petaccia, do Nascimento, Ellen Caroline Toledo, Testagrossa, Leonardo de Abreu, Katz, Artur
Publicado 2022